Aspen scores partnership agreement with US biotech group
The transaction gives the pharmaceutical company access to therapeutic areas with high growth potential
04 May 2023 - 15:29
SA’s biggest generic drugmaker, Aspen Pharmacare, has bagged a deal that will give it exclusive rights to market, distribute, use and sell Amgen’s products in the country.
The R83bn JSE-listed pharmaceutical giant said on Thursday that the transaction will be for an initial term of five years, which it expects will be renewed...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.